Breaking News
0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Cardinal Health Stock A Buy: Healthy Gains On The Way

By MarketBeat.com (Sean Sechler )Stock MarketsMar 31, 2021 05:25AM ET
www.investing.com/analysis/cardinal-health-stock-a-buy-healthy-gains-on-the-way-200570496
Cardinal Health Stock A Buy: Healthy Gains On The Way
By MarketBeat.com (Sean Sechler )   |  Mar 31, 2021 05:25AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 

While the market has been somewhat difficult to get a read on lately, there’s still plenty of great opportunities out there for investors to consider including Cardinal Health (NYSE:CAH).

Anytime a stock breaks out from a three-year consolidation pattern, it’s worth paying attention to. It’s even better if said stock happens to be a high-quality business trading at a very attractive valuation. This is exactly the case with Cardinal Health, which has so much to offer investors at this time.

As one of the top 3 U.S. distributors of pharmaceuticals, this health care company is one of the top picks in its sector given its growth prospects and strong competitive position. It’s the type of stock that you can rely on as the cornerstone of your portfolio for years to come.

Let’s take a deeper look at this company’s business below and review some strong supporting points about why the stock is a buy at this time.

A Healthy Business Model

If you aren’t very familiar with the pharmaceutical distribution industry, it’s important to note that three big companies control 90% of the U.S. market share. Those three companies are McKesson (NYSE:MCK), AmerisourceBergen (NYSE:ABC), and Cardinal Health.

This is one of the great reasons to consider adding shares of Cardinal Health since there are big barriers to entry into the industry thanks to a highly-regulated environment. That means Cardinal Health should retain its leading market position for years to come and continue benefitting from the sheer scale of the pharma industry.

Cardinal Health essentially connects the manufacturers of pharmaceuticals and medical supplies with a huge range of customers that includes pharmacies, hospitals, physician offices, clinical labs, outpatient surgery centers, and more.

Two of the company’s biggest customers are CVS Health Corp (NYSE:CVS) and OptumRx. Cardinal has deals locked in with them until 2023 and 2024, respectively. It’s also worth mentioning that Cardinal Health has more exposure to medical supplies manufacturing and distribution than the other “big three” companies, which could enable it to eventually become the go-to company for health care providers in need of medical supplies and medicines.

Numerous Growth Drivers

We know that the healthcare industry will continue to grow over the years, and the global pandemic has only highlighted the importance of companies that are involved in keeping the world in good health. That bodes well for a company like Cardinal Health, which should see strong earnings in 2021 and beyond.

Consider the fact that the world’s population is constantly aging and will require more health care products and services each year. You also have to like Cardinal’s growth prospects as elective procedures pick up again as people get more comfortable with the idea of heading back to the doctor for non-essential care.

Don’t forget about President Joe Biden’s stance on health care and his plans to build upon the Affordable Care Act, which could be another strong catalyst for this company.

Finally, the fact that Cardinal Health became a network administrator of the Federal Pharmacy Partnership Strategy for COVID-19 will help the company play a critical role in one of the largest mass vaccination programs of all time, should be viewed as a strong growth opportunity. It's safe to say that there are plenty of ways this company can reward long-term shareholders who are along for the ride.

Dividend Aristocrat And Bargain Valuation

If you still aren’t sold on Cardinal Health, keep in mind that this company is a dividend aristocrat and could be a nice way to generate income over the years. The stock currently offers investors a 3.11% dividend yield and increased its dividend payout for 32 consecutive years at this time.

While the company’s dividend growth rate isn’t necessarily special, the fact that the share price has been benefitting from share buyback programs over the years and that the company is consistent in its dividend growth is confirmation that this is a well-run company that loves to reward its shareholders.

While the company’s share price has been depressed due to the company’s issues related to its role in the opioid crisis, there’s a good chance that those issues have been resolved and that investors are still undervaluing this great company.

When you compare Cardinal Health’s P/E ratio of 13x with the 42x P/E ratio for the S&P 500, it’s clear that this is a stock trading at a bargain valuation. The bottom line here is that Cardinal Health stands out in a market full of overvalued companies and is a strong buy given its recent breakout.

Original Post

Cardinal Health Stock A Buy: Healthy Gains On The Way
 

Related Articles

Tim Knight
DraftKings In A Very Dangerous Position By Tim Knight - May 07, 2021 3

This is a good real-life example of how charting can be very helpful in giving warnings that something is going wrong. Below is the chart of DraftKings Inc (NASDAQ:DKNG) without...

Cardinal Health Stock A Buy: Healthy Gains On The Way

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email